Notice of Change in Due Date and Expiration Date for Alzheimer's Disease Funding Opportunity Announcements: RFA-AG-13-013, RFA-AG-13-015, and RFA-AG-13-016
RFA-AG-13-013: Interdisciplinary Approach to Identification and Validation of Novel Therapeutic Targets for Alzheimer's Disease (R01)
RFA-AG-13-015: Alzheimer's Disease Prevention Trials (R01)
RFA-AG-13-016: Alzheimer's Disease Phase I Clinical Trials (R01)
Notice Number: NOT-AG-12-020
Key Dates
Release Date: December 12, 2012
RFA-AG-13-013: Interdisciplinary Approach to Identification and Validation of Novel Therapeutic Targets for Alzheimer's Disease (R01)
RFA-AG-13-015: Alzheimer's Disease Prevention Trials (R01)
RFA-AG-13-016: Alzheimer's Disease Phase I Clinical Trials (R01)
Issued by
National Institute on Aging (NIA)
Purpose
The three Funding Opportunity Announcements (FOAs) for the Alzheimer's Disease initiative (RFA-AG-13-013, RFA-AG-13-015, and RFA-AG-13-016) were issued with a due date of January 13, 2013 which is a Sunday. Therefore, the due date is changed to January 14, 2013 and expiration date is changed to January 15, 2013 for these three FOAs.
Inquiries
Please direct all inquiries to:
Ramesh Vemuri, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9696
Email: [email protected]
Department of Health
and Human Services (HHS)
and Human Services (HHS)
